Radiomic markers associated with clinical benefit in patients with radiographic progression of advanced uveal melanoma on tebentafusp

Beylergil, V., Collins, L., Schwartz, L. H., Eche, T., Zhao, B., Champiat, S., Carvajal, R., Abedin, S. E., & Dercle, L. (2025). Radiomic markers associated with clinical benefit in patients with radiographic progression of advanced uveal melanoma on tebentafusp. European Journal of Cancer, 220, 115386. https://doi.org/10.1016/j.ejca.2025.115386
Authors:
Volkan Beylergil
Laura Collins
Lawrence H Schwartz
Thomas Eche
Binsheng Zhao
Stephane Champiat
Richard Carvajal
Shaad E Abedin
Laurent Dercle
Affiliated Authors:
Volkan Beylergil
Lawrence H Schwartz
Thomas Eche
Binsheng Zhao
Richard Carvajal
Laurent Dercle
Subjects:
Author Keywords:
tebentafusp
metastatic uveal melanoma
circulating tumor dna (ctdna)
radiomics analysis
tumor heterogeneity
Publication Type:
Article
Unique ID:
10.1016/j.ejca.2025.115386
PMID:
Publication Date:
Data Source:
PubMed

Record Created: